Skip to content

Evaluation of the alteration of spiroergometric parameters for CAD-patients after recanalization of chronic occluded coronary arteries (CTO)

Evaluation of the alteration of spiroergometric parameters for CAD-patients after recanalization of chronic occluded coronary arteries (CTO)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00009293
Enrollment
50
Registered
2015-10-02
Start date
2013-10-17
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Total coronary occlusions I25.11

Interventions

Group 1: This study is supposed to prove the efficiancy of CTO (recanalization of chronic occluded coronary arteries)-procedures in matters of the physiologic performance parameters on the basis of th

Sponsors

Helios ForschungszentrumHelios Research Center GmbH Berlin Deutschland
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: -diagnosis: atherosclerotic hearts disease with one ore more Chronic Total coronary occlusions -demonstration of a chronic occluded main vessel with clinical symptoms (angina pectoris, dyspnoea, cardiac insufficiency) independent from severity and length of disease - proof of vitality of the less perfused supply zone of the myocardium - for our study we only recruit patient with successful coronary vessel recanalization

Exclusion criteria

Exclusion criteria: - refusal of the spiroergometry for several reasons (pre-existing orthopedic, pulmonic, neurologic diseases) that make an adequate stress impossible - expected incompliance due to the target stress level, the optimum medical therapy or fulfilment of medical appointments - additional coronary interventions during the observation period -malignant diseases and other accompanying diseases which might lead to a reduced physical resilience for other reasons - participation in another clinical trial - all patients who did not get an optimum medical therapy - patient with newly-discovered severe diseases - severe vitiums - pregnancy or lactation - existing addictive disorders

Design outcomes

Primary

MeasureTime frame
Measurement of the maximum oxygen uptake during spiroergometry 6 months after CTO

Countries

Germany

Contacts

Public ContactKambis Mashayekhi

HELIOS Vogtland Klinikum

kambis.mashayekhi@helios-kliniken.de03741-490

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026